https://tissuepathology.com Educational and informative Mon, 04 May 2026 12:25:23 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/05/04/connect-with-deciphex-in-dublin/ Mon, 04 May 2026 12:25:23 +0000 https://tissuepathology.com/?p=24394 From Deciphex on LinkedIn: Next Tuesday, our CEO Donal O’Shea takes the stage at the MedTech Strategist Innovation Summit in Dublin. Donal will be joining the “Breaking In: Rolling out Medtech in Europe” commercialisation panel, sharing the hard-won perspective that comes from building and scaling AI-driven digital pathology across some of the world’s most complex […]

The post Connect with Deciphex in Dublin! first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/24/panakeia-unveils-landmark-metabolic-and-pathway-activation-data-in-cancers-at-aacr-2026/ Fri, 24 Apr 2026 12:37:33 +0000 https://tissuepathology.com/?p=24377 CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual Meeting 2026, further proving its unique capability to unlock complete biological blueprints essential for drug discovery and clinical decision-making. The Company revealed […]

The post Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026 first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/20/lunit-to-present-six-ai-studies-at-aacr-2026-highlighting-advances-in-precision-oncology-and-real-world-clinical-application/ Mon, 20 Apr 2026 11:32:31 +0000 https://tissuepathology.com/?p=24360 Lunit: AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor microenvironment not captured by conventional methods, and enable integrated analysis to better support treatment decision-making. SEOUL, South Korea, April 17, 2026 /PRNewswire/ — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, […]

The post Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/16/visit-diagnexia-at-the-executive-war-college-conference-2026/ Thu, 16 Apr 2026 12:07:17 +0000 https://tissuepathology.com/?p=24354 Diagnexia is attending The Executive War College Conference 2026! Pathology labs are under growing pressure with staffing gaps, costly locums, and rising caseloads putting diagnostic quality and turnaround times at risk. Join Diagnexia in New Orleans, LA April 28-29 to see how we deliver CLIA-compliant, subspecialty pathology coverage on demand. Consistent, high-quality reads Seamless support […]

The post Visit Diagnexia at The Executive War College Conference 2026 first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/09/bioaffinity-technologies-cypath-lung-to-be-featured-at-cleveland-clinic-annual-advances-in-early-lung-cancer-detection-symposium-april-16/ Thu, 09 Apr 2026 13:28:03 +0000 https://tissuepathology.com/?p=24341 bioAffinity Technologies: Invitation-only conference focuses on the evolving landscape of lung cancer risk and early detection when the disease is most treatable bioAffinity Technologies Chief Medical Officer Gordon Downie, MD, PhD, to participate in panel on lung nodule management  SAN ANTONIO, TX – April 7, 2026 – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused […]

The post bioAffinity Technologies’ CyPath® Lung to be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2025/12/09/leica-biosystems-expands-clinical-digital-pathology-portfolio-with-multiple-launches-at-dpai-2025/ Tue, 09 Dec 2025 14:36:56 +0000 https://tissuepathology.com/?p=24103 VISTA, California, December 9, 2025 – Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is driving the future of clinical diagnostics with another bold step forward in the digital transformation of pathology, launching the Aperio GT 180 DX scanner, Aperio CS5 DX scanner, and Aperio iQC DX software during the […]

The post Leica Biosystems Expands Clinical Digital Pathology Portfolio with Multiple Launches at DPAI 2025 first appeared on Tissuepathology.com.]]>